Form 4: Humana Inc. Executive George Renaudin II Reports Changes in Beneficial Ownership
SEC Form 4
Humana Inc. executive George Renaudin II reports transactions involving company stock, including acquisitions of phantom stock units and holdings in retirement savings plans.
Summary
- George Renaudin II, a President at Humana Inc., filed a Form 4 detailing changes in his beneficial ownership of Humana securities.
- The report includes transactions related to Humana common stock, stock options, restricted stock units, and phantom stock units.
- On March 27, 2025, Renaudin acquired 5 phantom stock units at a price of $270.38.
- He directly owns 15,702 shares of Humana common stock and indirectly owns 512 shares through the Humana Retirement Savings Plan.
- He also holds options to purchase 4,162 shares at $510.2425 and 6,966 shares at $367.21.
- Additionally, he possesses 609 and 360 restricted stock units, and 170 phantom stock units.
Sentiment
Score: 6
Explanation: The document is a standard regulatory filing, so the sentiment is neutral. The executive's continued holdings suggest confidence in the company, but it's not overtly positive.
Positives
- The reporting person's holdings include a mix of stock options, restricted stock units, and direct stock ownership, indicating a vested interest in the company's long-term performance.
Future Outlook
The document does not contain explicit forward-looking statements, but the vesting schedules of stock options and restricted stock units suggest continued employment and investment in the company's future.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. This filing indicates the executive's continued investment in Humana.
Comparison to Industry Standards
- Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
- The vesting schedules and exercise prices of the options and restricted stock units are typical for executive compensation plans in publicly traded companies like Humana.
- Comparing the size of Renaudin's holdings and transactions to those of executives at similar healthcare companies (e.g., UnitedHealth Group, CVS Health) would provide further context.
Stakeholder Impact
- The filing provides transparency to shareholders regarding the executive's holdings and transactions.
- It can influence investor sentiment, although Form 4 filings are generally considered routine.
Key Dates
| Date | Description |
|---|---|
| 02/24/2023 | Grant date of incentive and non-qualified stock options, vesting in three annual increments from 2/24/24 to 2/24/26. |
| 02/21/2024 | Grant date of incentive and non-qualified stock options, vesting in three annual increments from 2/21/25 to 2/21/27. |
| 02/28/2025 | Shares held for the benefit of reporting person as of this date under the Humana Retirement Savings Plan. |
| 03/27/2025 | Date of transaction involving phantom stock units. |
| 03/31/2025 | Date of Form 4 signature. |
| 10/01/2025 | Vesting date for 100% of the 609 restricted stock units granted on 10/1/2022. |
| 12/15/2025 | Final vesting date for the 360 restricted stock units granted on 2/24/2023. |
Keywords
Form 4, Beneficial Ownership, Humana, Renaudin, Stock Options, Restricted Stock Units, Phantom Stock Units, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.